These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 29733870)

  • 1. Prevalence and geographical distribution of insulin pump therapy in the Central Denmark Region and its association with metabolic parameters.
    Kampmann U; Madsen LR; Bjerg L; Witte DR; Hasselstrøm K; Østergård T; Alstrup K; Møller MK; Dylmer D; Hansen KW
    Diabetes Res Clin Pract; 2018 Jul; 141():148-155. PubMed ID: 29733870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Modality-Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study.
    Hoshina S; Andersen GS; Jørgensen ME; Ridderstråle M; Vistisen D; Andersen HU
    Diabetes Technol Ther; 2018 Mar; 20(3):229-234. PubMed ID: 29437465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections.
    Birkebaek NH; Kristensen LJ; Mose AH; Thastum M;
    Diabetes Res Clin Pract; 2014 Dec; 106(3):474-80. PubMed ID: 25451903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark.
    Roze S; de Portu S; Smith-Palmer J; Delbaere A; Valentine W; Ridderstråle M
    Diabetes Res Clin Pract; 2017 Jun; 128():6-14. PubMed ID: 28432898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry.
    Szypowska A; Schwandt A; Svensson J; Shalitin S; Cardona-Hernandez R; Forsander G; Sundberg F; De Beaufort C; Maahs D; Maffeis C; O'Riordan SM; Krisane ID; Scharf M; Castro S; Konstantinova M; Obermannova B; Casteels K; Gökşen D; Galhardo J; Kanaka-Gantenbein C; Rami-Merhar B; Madacsy L;
    Pediatr Diabetes; 2016 Oct; 17 Suppl 23():38-45. PubMed ID: 27417128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for Insulin Pump Therapy in Type 1 Diabetes and Associations With Glycemic Control.
    Jendle JH; Rawshani A; Svensson AM; Avdic T; Gudbjörnsdóttir S
    J Diabetes Sci Technol; 2016 Sep; 10(5):1027-33. PubMed ID: 27226388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.
    Rosenlund S; Theilade S; Hansen TW; Andersen S; Rossing P
    Acta Diabetol; 2014 Dec; 51(6):955-62. PubMed ID: 25274393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nationwide study of continuous subcutaneous insulin infusion (CSII) in Denmark.
    Nørgaard K
    Diabet Med; 2003 Apr; 20(4):307-11. PubMed ID: 12675645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
    Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
    Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
    Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
    Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain.
    Beato-Víbora P; Chico-Ballesteros A; Giménez M; Guerrero-Vázquez R; Barrio-Castellanos R; Goñi-Iriarte MJ; Díaz-Soto G; Merino-Torres JF; Moreno-Fernández J; Martínez-Brocca MA;
    Diabetes Res Clin Pract; 2018 Mar; 137():56-63. PubMed ID: 29278712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopathology and continuous subcutaneous insulin infusion in type 1 diabetes.
    Rotella F; Lamanna C; Dicembrini I; Faravelli C; Calasso C; Mannucci E
    ScientificWorldJournal; 2013; 2013():672729. PubMed ID: 24170982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
    Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
    Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
    Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
    Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    ; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
    Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective.
    St Charles M; Lynch P; Graham C; Minshall ME
    Value Health; 2009; 12(5):674-86. PubMed ID: 19171006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.